pharmaceuticals

Sergey Puzyrevskiy: patents should not be used to restrict competition
Excessive protection of intellectual rights is not always an incentive for developing innovations and attracting investments
more
FAS: the support system for Russian pharmaceutical companies should not be build up on restricting the number of bidders
Russian pharmaceutical manufacturers should be supported through reducing administrative costs and developing export
more
Timophey Nizhegorodtsev: drug substitutability help prevent bid-rigging
Head of FAS Department for Control over Social Sphere and Trade, Timophey Nizhegorodtsev reviewed large-scale changes in the pharmaceutical sector in the past ten years
more
FAS addressed medical institutions
FAS asked medical institutions to submit information about the issue related to absence of approved licensing requirements
more
FAS opened a case against “Novartis Pharma” Ltd.
The company is suspected of fixing monopolistically high price for “Tyverb” medicinal drug
more

Site Map

News & Events Press Releases Image Library About FAS Russia What We Do Institutional Memory Mission, Goals, Values Priority Setting Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings Using our website International Cooperation Treaties & Agreements OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 OECD meetings 2019 OECD meetings 2020 OECD meetings 2021 FAS Annual Reports OECD-GVH RCC RCC Newsletter Projects ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD 18th session IGE UNCTAD 8th UN Conference on Competition 19th session IGE UNCTAD 20th session IGE UNCTAD 21th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Competition Law and Policy Centre BRICS Working Groups for the Research of Competition Issues in Socially Important markets Working Group for the Research of Competition Issues in the Pharmaceutical Markets Working Group for the Research of Competition Issues in the Food Value Chains Working Group for the Research of Competition Issues in the Automobile Markets Working Group for the Research of Competition Issues in the Digital Markets BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Document Library Legislation Reports & Analytics Cases & decisions COVID-19 Contacts Give feedback Contact us Links Authorities Worldwide